StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 5/30
$2.44−0.16 (-6.15%)

Close on Nov 20, 2026Market cap $84.82MP/E –Yield –

Anixa Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Anixa Biosciences's revenue for the twelve months ending Oct 31, 2023 was $210.00K. For fiscal 2024 it was $210.00K, up 0.0% from the year before. Over ten years it grew -13.9% a year on average. The highest annual figure on record is $9.26M in fiscal 2015.

Annual revenue

PeriodPeriod endValueChange
FY2024Oct 31, 2024$210.00K0.0%
FY2023Oct 31, 2023$210.00K-59.0%
FY2021Oct 31, 2021$512.00K+104.8%
FY2019Oct 31, 2019$250.00K-77.5%
FY2018Oct 31, 2018$1.11M+206.9%
FY2017Oct 31, 2017$362.50K+20.8%
FY2016Oct 31, 2016$300.00K-96.8%
FY2015Oct 31, 2015$9.26M+152.4%
FY2014Oct 31, 2014$3.67M+843.1%
FY2013Oct 31, 2013$388.85K-58.6%
FY2012Oct 31, 2012$940.01K-6.3%
FY2011Oct 31, 2011$1.00M+37.3%
FY2010Oct 31, 2010$730.68K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ3 2023Oct 31, 2023$0-100.0%
Q3 FY2023CQ2 2023Jul 31, 2023$0–
Q2 FY2023CQ1 2023Apr 30, 2023$210.00K–
Q2 FY2022CQ1 2022Apr 30, 2022$0–
Q1 FY2022CQ4 2021Jan 31, 2022$513.00K0.0%
Q4 FY2021CQ3 2021Oct 31, 2021$0–
Q3 FY2021CQ2 2021Jul 31, 2021$0–
Q2 FY2021CQ1 2021Apr 30, 2021$0-100.0%
Q1 FY2021CQ4 2020Jan 31, 2021$513.00K–
Q4 FY2019CQ3 2019Oct 31, 2019$0-100.0%
Q3 FY2019CQ2 2019Jul 31, 2019$0-100.0%
Q2 FY2019CQ1 2019Apr 30, 2019$250.00K–
Q4 FY2018CQ3 2018Oct 31, 2018$0-100.0%
Q3 FY2018CQ2 2018Jul 31, 2018$362.50K+81.3%
Q2 FY2018CQ1 2018Apr 30, 2018$750.00K–
Q4 FY2017CQ3 2017Oct 31, 2017$0–
Q3 FY2017CQ2 2017Jul 31, 2017$362.50K–
Q4 FY2016CQ3 2016Oct 31, 2016$200.00K–

More Anixa Biosciences figures

See a number that looks wrong?